Gerresheimer AG (GXIG)

57.800
-2.550(-4.23%)
  • Volume:
    119,755
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    57.550 - 60.500

GXIG Overview

Prev. Close
60.35
Day's Range
57.55-60.5
Revenue
1.57B
Open
59.7
52 wk Range
53.45-92.9
EPS
2.62
Volume
119,755
Market Cap
1.81B
Dividend (Yield)
1.25
(2.16%)
Average Vol. (3m)
96,357
P/E Ratio
23.28
Beta
0.944
1-Year Change
-35.02%
Shares Outstanding
31,400,000
Next Earnings Date
Oct 12, 2022
What is your sentiment on Gerresheimer AG?
or
Market is currently closed. Voting is open during market hours.

Gerresheimer AG News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Gerresheimer AG Company Profile

Gerresheimer AG Company Profile

Employees
10447
Market
Euro Zone
  • Type:Equity
  • Market:Germany
  • ISIN:DE000A0LD6E6
  • WKN:A0LD6E

Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging for pharma and cosmetics industries, such as infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; miniature bottles and glass containers for liquid food, spices, and spirits; and packaging solutions for fragrances, deodorants, skin care, and wellness products, as well as beauty and pharmaceutical products. The Advanced Technologies division develops smart drug delivery systems, such as micro pumps, which are used to self-administer medication for Parkinson’s disease or heart failure to pharmaceutical and biotech customers. The company was founded in 1864 and is headquartered in Düsseldorf, Germany.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell